JAFFAR HILLI M.D. NPI 1952657462

NPI Information

  • NPI: 1952657462
  • Provider Name: JAFFAR HILLI, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: ONE HOSPITAL DRIVE
    COLUMBIA, MO
    ZIP 65212
  • Phone: (573) 882-8445

Map and Directions

Get Directions

NPI Details

Jaffar Hilli, M.D. is a hematology and oncology internal medicine in Columbia, MO with 26 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Jaffar Hilli, M.D. NPI is 1952657462. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

ONE HOSPITAL DRIVE
COLUMBIA, MO
ZIP 65212-001
Phone: (573) 882-8445
Fax: (573) 884-7822

The NPI 1952657462 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Cyclophosphamide, 100 mg (HCPCS:J9070)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)

The enumeration date for this NPI number is 8/2/2012 and was last updated on 10/2/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyME171475FLORIDAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.